These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17683060)

  • 21. Crystal morphology modification by the addition of tailor-made stereocontrolled poly(N-isopropyl acrylamide).
    Munk T; Baldursdottir S; Hietala S; Rades T; Kapp S; Nuopponen M; Kalliomäki K; Tenhu H; Rantanen J
    Mol Pharm; 2012 Jul; 9(7):1932-41. PubMed ID: 22591051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-solvent co-crystallization of carbamazepine and saccharin.
    Wang IC; Lee MJ; Sim SJ; Kim WS; Chun NH; Choi GJ
    Int J Pharm; 2013 Jun; 450(1-2):311-22. PubMed ID: 23598078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and size control in anti-solvent crystallization of glycine with high frequency ultrasound.
    Nii S; Takayanagi S
    Ultrason Sonochem; 2014 May; 21(3):1182-6. PubMed ID: 24373692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered growth of organic crystalline films using liquid crystal solvents.
    Wilkinson FS; Norwood RF; McLellan JM; Lawson LR; Patrick DL
    J Am Chem Soc; 2006 Dec; 128(51):16468-9. PubMed ID: 17177373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.
    Chun NH; Wang IC; Lee MJ; Jung YT; Lee S; Kim WS; Choi GJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):854-61. PubMed ID: 23454054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development in modeling submicron particle formation in two phases flow of solvent-supercritical antisolvent emulsion.
    Dukhin SS; Shen Y; Dave R; Pfeffer R
    Adv Colloid Interface Sci; 2007 Oct; 134-135():72-88. PubMed ID: 17568550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound assisted crystallization of a new cardioactive prototype using ionic liquid as solvent.
    Resende de Azevedo J; Espitalier F; Ré MI
    Ultrason Sonochem; 2019 Jul; 55():32-43. PubMed ID: 31084789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colloidal crystallization of colloidal silica modified with ferrocenyl group-contained polymers in organic solvents.
    Yoshinaga K; Shigeta M; Komune S; Mouri E; Nakai A
    Colloids Surf B Biointerfaces; 2007 Jan; 54(1):108-13. PubMed ID: 17126537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous formation of polymer nanoparticles by good-solvent evaporation as a nonequilibrium process.
    Yabu H; Higuchi T; Ijiro K; Shimomura M
    Chaos; 2005 Dec; 15(4):047505. PubMed ID: 16396598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.
    Garala KC; Patel JM; Dhingani AP; Dharamsi AT
    Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of submicron-sized niflumic acid crystals prepared by electrospray crystallization.
    Ambrus R; Radacsi N; Szunyogh T; van der Heijden AE; Ter Horst JH; Szabó-Révész P
    J Pharm Biomed Anal; 2013 Mar; 76():1-7. PubMed ID: 23287488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystallization of progesterone for pulmonary drug delivery.
    Ragab D; Rohani S; Samaha MW; El-Khawas FM; El-Maradny HA
    J Pharm Sci; 2010 Mar; 99(3):1123-37. PubMed ID: 19691108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precipitation of lysozyme nanoparticles from dimethyl sulfoxide using carbon dioxide as antisolvent.
    Muhrer G; Mazzotti M
    Biotechnol Prog; 2003; 19(2):549-56. PubMed ID: 12675600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer Aided Design of Solvent Blends for Hybrid Cooling and Antisolvent Crystallization of Active Pharmaceutical Ingredients.
    Watson OL; Jonuzaj S; McGinty J; Sefcik J; Galindo A; Jackson G; Adjiman CS
    Org Process Res Dev; 2021 May; 25(5):1123-1142. PubMed ID: 34295139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of crystal habits on the surface energy and cohesion of crystalline powders.
    Shah UV; Olusanmi D; Narang AS; Hussain MA; Gamble JF; Tobyn MJ; Heng JY
    Int J Pharm; 2014 Sep; 472(1-2):140-7. PubMed ID: 24928138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
    DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
    J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.